Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
AssigneeChemGenex Therapeutics, Inc.
InventorDennis M. Brown
Life of this patent
Estimating the term…
Abstract
The present invention concerns novel methods for the synthesis of naphthalimides and mitonafide analogs, as well as salts thereof. Also included are novel compositions, including naphthalimides and naphthalimide salts, analogs thereof, as well as stable liquid dosage forms thereof.
Claims22
A method of synthesis of a nitro naphthalimide comprising:
- combining 3-nitro-1,8-naphthalic anhydride and an aliphatic diamine in an organic solvent to form a solution;
- and
- refluxing said solution.
A method of synthesis of mitonafide comprising:
- combining 3-nitro-1,8-naphthalic anhydride and N,N-dimethylethylenediamine in an organic solvent to form a solution;
- and
- refluxing said solution.
A method of synthesis of an amonafide analog comprising combining a mitonafide analog comprising a 3-nitro group, ammonium formate, and a catalyst in an organic solvent to reduce said 3-nitro group.
A method of synthesis of amonafide comprising combining mitonafide, ammonium formate, and a catalyst in an organic solvent.
A method of synthesis of a naphthalimide diammonium salt comprising:
- dissolving a naphthalimide in an organic solvent;
- and
- contacting said dissolved naphthalimide with an inorganic or organic acid to form a naphthalimide diammonium salt.
A composition comprising a naphthalimide as a diammonium salt.
A composition comprising a substituted 3-amino-naphthalimide salt.
An aqueous solution consisting essentially of a dissolved amonafide diammonium salt, said solution being suitable for administration by injection, said solution comprising amonafide at between 1 and 250 mg/mL, said solution having a pH between 4.0 and 7.0.
An aqueous solution of amonafide, said solution being suitable for administration by injection, said solution comprising amonafide at between 10 and 100 mg/mL, and said solution having a pH between 5.5 and 6.5.
A method for manufacturing a sterile pharmaceutical composition comprising a naphthalimide diammonium salt suitable for administration to a human, said method comprising:
- (a) solubilizing a naphthalimide diammonium salt in an aqueous solution;
- (b) neutralizing the aqueous solution with a molar equivalent of base;
- (c) adjusting the pH of the solution comprising said solubilized naphthalimide diammonium salt to about 6;
- and
- (d) sterilizing said solution.
Dependencies are inferred from the claim text.